These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8987714)

  • 21. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
    Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
    J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.
    Chart H; Smith HR; Scotland SM; Rowe B; Milford DV; Taylor CM
    Lancet; 1991 Jan; 337(8734):138-40. PubMed ID: 1670788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay for detection of Shiga toxin-producing Escherichia coli infection by antibodies to Escherichia coli secreted protein B in children with hemolytic uremic syndrome.
    Sjögren AC; Kaper JB; Caprioli A; Karpman D
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):208-11. PubMed ID: 14986162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a latex agglutination kit for the detection of human antibodies to the lipopolysaccharide of Escherichia coli O157, following infection with verocytotoxin-producing E. coli O157.
    Chart H
    Lett Appl Microbiol; 1999 Dec; 29(6):434-6. PubMed ID: 10664989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli.
    Chart H; Jenkins C
    J Appl Microbiol; 1999 May; 86(5):731-40. PubMed ID: 10347867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemolytic-uremic syndrome after verotoxin-producing Escherichia coli infection].
    Mariani-Kurkdjian P; Bingen E
    Presse Med; 1995 Jan; 24(2):99-101. PubMed ID: 7899353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to lipopolysaccharides of Escherichia coli serogroups O5 and O165 in healthy adults.
    Jenkins C; Chart H
    Lancet; 1999 Aug; 354(9179):649-50. PubMed ID: 10466672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibodies to secreted proteins in patients infected with Escherichia coli O157 and other VTEC.
    Chart H; Jenkins C; Smith HR; Rowe B
    Epidemiol Infect; 1998 Jun; 120(3):239-43. PubMed ID: 9692601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verocytotoxin-producing Escherichia coli and the haemolytic uraemic syndrome.
    Taylor CM
    J Infect; 1995 May; 30(3):189-92. PubMed ID: 7673740
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B; Bouvet P; Mariani-Kurkdjian P; Grimont F; Grimont PA; Hubert B; Loirat C
    Epidemiol Infect; 2000 Apr; 124(2):215-20. PubMed ID: 10813145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human antibody responses to R3-core epitopes on the lipopolysaccharide of Escherichia coli O157.
    Dalwai F; Chart H
    Lett Appl Microbiol; 2003; 37(6):429-32. PubMed ID: 14633093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal diagnostics in combination with serology: best test to establish STEC-HUS.
    Wijnsma KL; van Bommel SA; van der Velden T; Volokhina E; Schreuder MF; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2016 Nov; 31(11):2163-70. PubMed ID: 27240858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.
    Bitzan M; Ludwig K; Klemt M; König H; Büren J; Müller-Wiefel DE
    Epidemiol Infect; 1993 Apr; 110(2):183-96. PubMed ID: 8472763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.
    Bitzan M; Karch H
    J Clin Microbiol; 1992 May; 30(5):1174-8. PubMed ID: 1583116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of O-serogroup serodiagnosis for patients with hemolytic uremic syndrome by Ec-LPS array].
    Amano K; Yatsuyanagi J; Saito S
    Kansenshogaku Zasshi; 2007 Jan; 81(1):26-32. PubMed ID: 17338313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.
    Evans J; Chalmers RM; Chart H; Salmon RL; Kench SM; Coleman TJ; Meadows D; Morgan-Capner P; Softley P; Sillis M; Thomas DR
    Eur J Epidemiol; 2000; 16(10):885-9. PubMed ID: 11338118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Four cases of hemolytic uremic syndrome (HUS) associated with serotype O165 verotoxin producing Escherichia coli (VTEC) identified by LPS-solid phase enzyme-linked immunosorbent assay (ELISA)].
    Uchida H; Kanegane H; Yoshiya K; Kitamura K; Ihara T; Kamiya H; Kobayashi Y; Miyazawa H; Takeda T
    Kansenshogaku Zasshi; 1995 Jun; 69(6):678-83. PubMed ID: 7616014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide.
    Chart H; Rowe B
    J Infect; 1992 May; 24(3):257-61. PubMed ID: 1602146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.